Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Altamura

Showing results (51-60 of 113) with videos related to

Pageof 12
Sort By:
Journal of Affective Disorders|April 17, 2017
Pituitary gland in Bipolar Disorder and Major Depression: Evidence from structural MRI studies: Special Section on "Translational and Neuroscience Studies in Affective Disorders". Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summarise relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disordersG Delvecchio, A C Altamura, J C Soares, et al.
Acta Psychiatrica Scandinavica|December 1, 1987
Clonazepam/haloperidol combination therapy in schizophrenia: a double blind studyA C Altamura, M C Mauri, M Mantero, et al.
Clinical Neuropharmacology|January 1, 1990
Alternative prophylactic treatments to lithium in bipolar disordersM C Mauri, M Percudani, M G Regazzetti, et al.
Psychopharmacology|January 1, 1985
Early unwanted effects of fluphenazine esters related to plasma fluphenazine concentrations in schizophrenic patientsA C Altamura, S H Curry, S Montgomery, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1987
Plasma and brain pharmacokinetics of mianserin after single and multiple dosing in miceA C Altamura, F De Novellis, M C Mauri, et al.
Schizophrenia Research|December 31, 2002
Clinical variables related to suicide attempts in schizophrenic patients: a retrospective studyA C Altamura, R Bassetti, S Bignotti, et al.
Schizophrenia Research|October 12, 2001
Duration of untreated psychosis as a predictor of outcome in first-episode schizophrenia: a retrospective studyA C Altamura, R Bassetti, F Sassella, et al.
Acta Neurologica|February 1, 1986
Orphenadrine plasma levels and amelioration of extrapyramidal side effects in schizophrenic patients treated with haloperidolA C Altamura, M Buccio, F Colacurcio, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1987
Fluphenazine decanoate in acute and maintenance therapy of schizophreniaA C Altamura, M C Mauri, G Guercetti, et al.
International Journal of Psychiatry in Clinical Practice|June 17, 2014
Is olanzapine better than haloperidol in resistant schizophrenia? A double-blind study in partial respondersA C Altamura, I VelonĂ , R Curreli, et al.
Pageof 12

Showing results (51-60 of 113) with videos related to

Sort By:
Pageof 12
Journal of Affective Disorders|April 17, 2017
Pituitary gland in Bipolar Disorder and Major Depression: Evidence from structural MRI studies: Special Section on "Translational and Neuroscience Studies in Affective Disorders". Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summarise relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disordersG Delvecchio, A C Altamura, J C Soares, et al.
Acta Psychiatrica Scandinavica|December 1, 1987
Clonazepam/haloperidol combination therapy in schizophrenia: a double blind studyA C Altamura, M C Mauri, M Mantero, et al.
Clinical Neuropharmacology|January 1, 1990
Alternative prophylactic treatments to lithium in bipolar disordersM C Mauri, M Percudani, M G Regazzetti, et al.
Psychopharmacology|January 1, 1985
Early unwanted effects of fluphenazine esters related to plasma fluphenazine concentrations in schizophrenic patientsA C Altamura, S H Curry, S Montgomery, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1987
Plasma and brain pharmacokinetics of mianserin after single and multiple dosing in miceA C Altamura, F De Novellis, M C Mauri, et al.
Schizophrenia Research|December 31, 2002
Clinical variables related to suicide attempts in schizophrenic patients: a retrospective studyA C Altamura, R Bassetti, S Bignotti, et al.
Schizophrenia Research|October 12, 2001
Duration of untreated psychosis as a predictor of outcome in first-episode schizophrenia: a retrospective studyA C Altamura, R Bassetti, F Sassella, et al.
Acta Neurologica|February 1, 1986
Orphenadrine plasma levels and amelioration of extrapyramidal side effects in schizophrenic patients treated with haloperidolA C Altamura, M Buccio, F Colacurcio, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1987
Fluphenazine decanoate in acute and maintenance therapy of schizophreniaA C Altamura, M C Mauri, G Guercetti, et al.
International Journal of Psychiatry in Clinical Practice|June 17, 2014
Is olanzapine better than haloperidol in resistant schizophrenia? A double-blind study in partial respondersA C Altamura, I VelonĂ , R Curreli, et al.
Pageof 12